This topic contains a solution. Click here to go to the answer

Author Question: Studies of the long-term course of obsessive-compulsive disorder indicate that which of the ... (Read 24 times)

stephzh

  • Hero Member
  • *****
  • Posts: 556
Studies of the long-term course of obsessive-compulsive disorder indicate that which of the following is true?
 
  a. 60 percent of patients demonstrate recovery after one year.
  b. At a 40-year follow-up, approximately 30 percent show improvement.
  c. Approximately 50 percent of patients still show symptoms after 30 years.
  d. A higher percentage of females than males had not relapsed after 30 years.

Question 2

Which of the following is true as to the course of anxiety disorders?
 
  a. The long-term outcome of individuals with anxiety disorder is mixed and unpredictable.
  b. Individuals with agoraphobia avoidance tend to get over their fears with age.
  c. The frequency and intensity of anxiety attacks tend to increase with age.
  d. Patients with generalized anxiety disorder may find their physical symptoms replaced with worries .



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

annierak

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

Answer: c.

Answer to Question 2

Answer: a.




stephzh

  • Member
  • Posts: 556
Reply 2 on: Jun 22, 2018
Gracias!


kswal303

  • Member
  • Posts: 316
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library